Alan J. Forster, MD, FRCPC, MSc; Harvey J. Murff, MD; Josh F. Peterson, MD; Tejal K. Gandhi, MD, MPH; David W. Bates, MD, MSc
Among patients discharged home from a general medical service, adverse events occurred frequently in the peridischarge period. Many of these events might have been prevented or ameliorated with simple strategies.
Ann Intern Med. 2003;138(3):161-167. doi:10.7326/0003-4819-138-3-200302040-00007
Patricia A. Carney, PhD; Diana L. Miglioretti, PhD; Bonnie C. Yankaskas, PhD; Karla Kerlikowske, MD; Robert Rosenberg, MD; Carolyn M. Rutter, PhD; Berta M. Geller, EdD; Linn A. Abraham, MS; Steven H. Taplin, MD, MPH; Mark Dignan, PhD; Gary Cutter, PhD; Rachel Ballard-Barbash, MD, MPH
Mammographic breast density and age are important predictors of the accuracy of screening mammography. Although use of hormone replacement therapy is not an independent predictor of accuracy, it probably affects accuracy by increasing breast density.
Ann Intern Med. 2003;138(3):168-175. doi:10.7326/0003-4819-138-3-200302040-00008
John M. Inadomi, MD; Richard Sampliner, MD; Jesper Lagergren, MD; David Lieberman, MD; A Mark Fendrick, MD; Nimish Vakil, MD
Screening 50-year-old men with symptoms of gastroesophageal reflux disease to detect adenocarcinoma associated with Barrett esophagus is probably cost-effective. However, subsequent surveillance of patients with Barrett esophagus but no dysplasia, even at 5-year intervals, is expensive.
Ann Intern Med. 2003;138(3):176-186. doi:10.7326/0003-4819-138-3-200302040-00009
Scott A. Allen, MD; Anne C. Spaulding, MD; Albert M. Osei, MD; Lynn E. Taylor, MD; Asya M. Cabral, MPH; Josiah D. Rich, MD, MPH
The incarcerated population can be effectively treated for hepatitis C virus infection with interferon and ribavirin. The correctional setting may provide an opportunity to safely treat patients with these two challenging comorbid conditions.
Ann Intern Med. 2003;138(3):187-190. doi:10.7326/0003-4819-138-3-200302040-00010
Mark S. Sulkowski, MD; David L. Thomas, MD
The authors discuss the management of hepatitis C in HIV-infected persons by using the available literature to provide recommendations and, when necessary, highlight controversial areas.
Ann Intern Med. 2003;138(3):197-207. doi:10.7326/0003-4819-138-3-200302040-00012
U.S. Preventive Services Task Force*
The U.S. Preventive Services Task Force concludes that the evidence is insufficient to recommend for or against routinely screening asymptomatic adults for type 2 diabetes, impaired glucose tolerance, or impaired fasting glucose. The Task Force recommends screening for type 2 diabetes in adults with hypertension or hyperlipidemia.
Ann Intern Med. 2003;138(3):212-214. doi:10.7326/0003-4819-138-3-200302040-00014
Russell Harris, MD, MPH; Katrina Donahue, MD, MPH; Saif S. Rathore, MPH; Paul Frame, MD; Steven H. Woolf, MD, MPH; Kathleen N. Lohr, PhD
This systematic review supports the U.S. Preventive Services Task Force's position on screening adults for type 2 diabetes.
Ann Intern Med. 2003;138(3):215-229. doi:10.7326/0003-4819-138-3-200302040-00015
Miriam S. Wetzel, PhD; Ted J. Kaptchuk, OMD; Aviad Haramati, PhD; David M. Eisenberg, MD
This article examines how to incorporate complementary and alternative medical therapies as an integral part of the medical curriculum. It offers practical suggestions for finding time in an already packed curriculum, getting started, including faculty and students in the process, and sustaining the initiative with the necessary administrative and institutional support.
Ann Intern Med. 2003;138(3):191-196. doi:10.7326/0003-4819-138-3-200302040-00011
Mark H. Eckman, MD; John K. Erban, MD; Sushil K. Singh, MD; Grace S. Kao, MD
Ann Intern Med. 2003;138(3):W-15W-24. doi:10.7326/0003-4819-138-3-200302040-00011-w1
Timothy E. Quill, MD; Christine K. Cassel, MD
Position statements opposing legalization of physician-assisted suicide generally understate the limitations of palliative care to alleviate some end-of-life suffering, and they do not provide adequate guidance about how physicians should approach patients with intractable suffering when they wish to die. The authors argue in favor of medical organizations' taking a position of studied neutrality on this contentious issue.
Ann Intern Med. 2003;138(3):208-211. doi:10.7326/0003-4819-138-3-200302040-00013
Harold C. Sox, MD, Editor
Primary care leaders and practitioners are concerned about the future of their specialty. In a supplement to this issue, they explain their concerns and offer suggestions based on discussions at a conference on the Future of Primary Care held in October 2001. This editorial underscores some of the reasons for concern, highlights key elements of the mission of primary care, and identifies points of leverage for renewal of the field.
Ann Intern Med. 2003;138(3):230-232. doi:10.7326/0003-4819-138-3-200302040-00016
Paul B. Ginsburg, PhD
This editorial discusses the recent history of payment for primary care services, the outlook for maintaining equity in relation to procedural services, and how payment structure could support the directions for primary care outlined in the primary care supplement.
Ann Intern Med. 2003;138(3):233-234. doi:10.7326/0003-4819-138-3-200302040-00020
Theodore M. Hammett, PhD
In this issue, Allen and colleagues demonstrate that a comprehensive approach to hepatitis C virus (HCV) in correctional facilities can be safely and effectively implemented. The failure of most correctional systems to implement systematic HCV programs means that they are missing an important opportunity to help reduce HCV transmission and thereby improve the health of the communities to which their inmates will return.
Ann Intern Med. 2003;138(3):235-236. doi:10.7326/0003-4819-138-3-200302040-00021
Ann Intern Med. 2003;138(3):237. doi:10.7326/0003-4819-138-3-200302040-00022
Ann Intern Med. 2003;138(3):237. doi:10.7326/0003-4819-138-3-200302040-00023
Ann Intern Med. 2003;138(3):237-238. doi:10.7326/0003-4819-138-3-200302040-00024
Ann Intern Med. 2003;138(3):238. doi:10.7326/0003-4819-138-3-200302040-00025
Ann Intern Med. 2003;138(3):238. doi:10.7326/0003-4819-138-3-200302040-00026
Ann Intern Med. 2003;138(3):238-239. doi:10.7326/0003-4819-138-3-200302040-00027
Ann Intern Med. 2003;138(3):239. doi:10.7326/0003-4819-138-3-200302040-00028
Jonathan Showstack, PhD, MPH; Arlyss Anderson Rothman, PhD, MHS, FNP; Susan Hassmiller, PhD, RN
Ann Intern Med. 2003;138(3):242-243. doi:10.7326/0003-4819-138-3-200302040-00031
Gordon Moore, MD, MPH; Jonathan Showstack, PhD, MPH
Ann Intern Med. 2003;138(3):244-247. doi:10.7326/0003-4819-138-3-200302040-00032
Dana Gelb Safran, ScD
Ann Intern Med. 2003;138(3):248-255. doi:10.7326/0003-4819-138-3-200302040-00033
Arlyss Anderson Rothman, PhD, MHS; Edward H. Wagner, MD, MPH
Ann Intern Med. 2003;138(3):256-261. doi:10.7326/0003-4819-138-3-200302040-00034
Lewis G. Sandy, MD; Steven A. Schroeder, MD
Ann Intern Med. 2003;138(3):262-267. doi:10.7326/0003-4819-138-3-200302040-00035
Jonathan Showstack, PhD, MPH; Nicole Lurie, MD, MSPH; Eric B. Larson, MD, MPH; Arlyss Anderson Rothman, PhD, MHS, FNP; Susan Hassmiller, PhD, RN
Ann Intern Med. 2003;138(3):268-272. doi:10.7326/0003-4819-138-3-200302040-00036
Ann Intern Med. 2003;138(3):I-16. doi:10.7326/0003-4819-138-3-200302040-00001
Ann Intern Med. 2003;138(3):I-28. doi:10.7326/0003-4819-138-3-200302040-00002
Ann Intern Med. 2003;138(3):I-41. doi:10.7326/0003-4819-138-3-200302040-00003
Ann Intern Med. 2003;138(3):I-50. doi:10.7326/0003-4819-138-3-200302040-00004
Ann Intern Med. 2003;138(3):I-52. doi:10.7326/0003-4819-138-3-200302040-00005
Raymond R. Townsend, MD
Ann Intern Med. 2003;138(3):240. doi:10.7326/0003-4819-138-3-200302040-00029
Elsa-Grace V. Giardina, MD
Ann Intern Med. 2003;138(3):240. doi:10.7326/0003-4819-138-3-200302040-00030
Ann Intern Med. 2003;138(3):No Pagination Specified. doi:10.7326/0003-4819-138-3-200302040-00037